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The E1A gene of adenovirus has been considered both a dominant oncogene and a tumor suppressor. It has been reported
to induce epithelial cell but to prevent myoblast differentiation. E1A enables oncogenes that are unable to transform primary
cells on their own to do so, yet suppresses tumor progression toward invasion and metastasis. To try to reconcile the
seemingly, conflicting E1A phenotypes, we examined the expression of epithelial cell specific and characterizing proteins in
immortalized or tumorigenically transformed primary epithelial cells expressing wild-type E1A or a C-terminal mutant that has
lost tumor suppressive abilities. All the cell types continued to express cytokeratin. Epithelial cell morphology, social
behavior, and growth characteristics were retained by cells expressing wild-type E1A, even in the presence of an activated
ras oncogene. Mutant E1A-expressing cells were less well differentiated even in the absence of ras. They were specifically
defective in cell–cell junctional complexes, such as tight and adherens junctions and desmosomes. There was also a
preference for those actin structures prominent in fibroblasts: stress fibers and filopodia, while in the wild-type E1A
expressing cells, cortical actin and circumferential actin filaments were dominant. Thus the E1A-mutant-expressing cells
were already predisposed to a more advanced tumor stage even when they were only immortalized and not transformed. The
results suggest the possibility that the C terminus of E1A may be involved in regulating epithelial mesenchymal transitions,
which have previously been linked to tumor progression. © 1998 Academic Press
Key Words: cell-cell junctional complexes; actin; cytoskeleton; EMT; MET.
INTRODUCTION
Epithelial cells exhibit apical-basolateral polarity
(Drubin and Nelson, 1996). They form contiguous
sheets of cells, which are immobile, by virtue of their
being closely linked to the adjacent cells by a series of
junctional complexes along their lateral surfaces
(Cowin and Burke, 1996; Gumbiner, 1996). At the most
apical location are the tight junctions (TJ; zonulae
occludens, occluding junctions) (Kim, 1995), followed
by the adherens junctions (AJ; zonulae adherens; for
review, see (Aberle et al., 1996; Marrs and Nelson,
1996), which associate with cortical actin filaments to
form a circumferential actin filament bundle (CAF).
Along the lateral surface are located the desmosomes
(for review, see Green and Jones, 1996), which asso-
ciate with intermediate filaments which are cytokera-
tins in epithelial cells (Steinert and Roop, 1988; Geor-
gatos and Maison, 1996; Chou et al., 1997). The social
behavior of epithelial cells is in sharp contrast with
fibroblasts or mesenchymal cells, which have front-to-
back end polarity and form only transient interactions
with other cells. Consequently, the expression of cell–
cell junctional complexes is down-regulated. Consis-
tent with their more mobile nature, fibroblasts exhibit
pseudopodia and filopodia, which are not seen in
epithelial cells. Transitions between these two cell
types, epithelial-mesenchymal (EMT) and mesenchy-
mal-epithelial (MET) occur during development in a
highly controlled manner (for review, see (Birchmeier
and Birchmeier, 1995; Hay, 1995; Prieto and Crossin,
1995). EMT is also a major contributor to the progres-
sion of a tumor toward malignancy (Valles et al., 1992;
Behrens et al., 1993; Birchmeier and Birchmeier, 1995;
Hay and Zuk, 1995; Birchmeier et al., 1996; Ruiz and
Gunthert, 1996). During EMT, an epithelialization gene
expression program is turned off, while a mesenchy-
mal gene expression program is activated.
Adenovirus (Ad) is a DNA tumor virus that normally
infects quiescent epithelial cells. When these cells
are of human origin, a productive lytic cycle ensues.
The virus is dependent upon the host replication ma-
chinery for its own replication. As a consequence,
mechanisms to activate cell cycle progression in
these cells have developed (Jansen-Durr, 1996). These
are carried out by the viral E1A gene (for review, see
Bayley and Mymryk, 1994), which is an immediate
early gene that encodes five transcripts generated by
differential splicing. The E1A 13S and 12S gene prod-
ucts of 289 and 243 aa, respectively, complex with key
cellular regulators of cell cycle, such as the pRB family
members, p60/cyclinA, and p33 cdk2, via peptides
contained in the N terminus (Egan et al., 1988; Gior-
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dano et al., 1989; Whyte et al., 1989; Faha et al., 1992;
for review, see Bayley and Mymryk, 1994). In a non-
permissive cell or in the absence of the rest of the
Ad genome, E1A can immortalize primary epithelial
cells such that they retain their differentiated charac-
teristics (Houweling et al., 1980; Quinlan and
Grodzicker, 1987; Quinlan and Douglas, 1992). In the
presence of another Ad gene, E1B, or some cellular
oncogenes, which are unable to transform primary
epithelial cells on their own, such as ras (Ruley, 1983)
or src (Fischer and Quinlan, 1998a), but not raf, mos,
rac, or cdc42 (Fischer and Quinlan, 1998b), tumori-
genic transformation occurs. Although, ras requires
the cooperation of an oncogene such as E1A, E1A can
also modulate the resultant transformed phenotype.
Coexpression of E1A genes with mutations in the
second exon, encoding the C terminus, results in a
hypertransforming phenotype, leading to invasive,
metastatic cells (Subramanian et al., 1989; Douglas et
al., 1991; Linder et al., 1992). The C terminus associ-
ates with a cellular protein, CTBP, which could there-
fore, be involved in this phenotype (Boyd et al., 1993;
Schaeper et al., 1995). Introduction of an intact E1A
has been shown to suppress metastatic potential in
some cells and to bring about epithelial cell differen-
tiation characteristics in others (for review, see Chin-
nadurai, 1992; Mymryk, 1996).
Tumorigenic transformation and progression is a mul-
tistep process involving the activation of dominant onco-
genes and the loss of tumor suppressor genes (Rhim et
al., 1990; Bishop, 1991; Buzard, 1996). Transformed cells
that exhibit the loss of growth control, but retain differ-
entiation including social behavior, are benign and less
problematic. Loss of differentiation characteristics and
acquisition of mobility are hallmarks of more aggres-
sively transformed cells, which are malignant and meta-
static (reviewed in Schoenenberger and Matlin, 1991;
Birchmeier and Birchmeier, 1995; Hay, 1995; Hay and
Zuk, 1995; Marell et al., 1995; Birchmeier et al., 1996; Ruiz
and Gunthert, 1996). Therefore, the two E1A phenotypes
of regulation of epithelial cell differentiation and modu-
lation of tumor progression may be connected. To inves-
tigate this possibility, we examined the expression of
several epithelial cell-specific and -distinguishing pro-
teins in epithelial cells expressing wild-type (WT) E1A
12S or a mutant that gives rise to the more aggressively
transformed phenotype (hypertransformation; HTx) with
activated ras (Douglas et al., 1991; Boyd et al., 1993).
Epithelial cells expressing WT12S were normal in their
morphology and social behavior, including cell–cell in-
teractions. However, epithelial cells expressing the hy-
pertransforming mutant were less well differentiated and
were specifically defective in the cell–cell junctional
complexes even in the absence of ras. Thus C-terminal
mutant-expressing cells were predisposed to a more
advanced transformation stage even when they were
only immortalized and not transformed. This suggests
that the C terminus of E1A may be involved in regulating
EMT/MET, which would reconcile many previous obser-
vations on the effects of E1A on differentiation, transfor-
mation, and tumor progression (see Mymryk, 1996).
FIG. 1. Morphology and keratin expression in WT12S- or HBdl12-expressing immortalized and transformed epithelial cells. Cells were grown on
glass coverslips and then fixed with paraformaldehyde (3.7%) for the phase contrast images at the top (A–D) and with ice-cold methanol for cytokeratin
immunofluorescence, bottom (E–H). (A and E) WT12S; (B and F) HBdl12; (C and G) WT12S1ras; (D and H) HBdl121ras. Photomicrographs were taken
at equal magnification.
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RESULTS
Epithelial cells expressing WT12S, but not C-terminal,
hypertransforming mutants, maintain epithelial cell
morphology
We and others have reported that E1A12S mutants
encoding polypeptides with mutated C termini (aa 191–
237 in the 243-aa polypeptide of 12S) give rise to more
aggressively transformed, metastatic cells in the pres-
ence of an activated ras gene, compared to wild-type
(WT) E1A (Subramanian et al., 1989; Douglas et al., 1991;
Linder et al., 1992). This hypertransformation has only
been observed with ras and not with activated raf, src, or
mos (Fischer and Quinlan, 1998a; Fischer et al., 1998a;
and unpublished observations). Epithelial cells express-
ing WT12S do not seem to lose their differentiated prop-
erties. Additionally, E1A has been considered a tumor
suppressor in some types of transformed cells. Loss of
differentiation accompanies and/or contributes to tumor
progression. Therefore, we set out to investigate the
possibility that the C terminus of E1A affects the differ-
entiated state of the cell, thereby affecting the extent of
transformation progression, at least in the context of ras.
To accomplish this, primary epithelial cells immortalized,
but not transformed, by WT12S or a C-terminal, ras-
hypertransforming mutant, HBdl12 (Quinlan and Douglas,
FIG. 2. Desmoglein localization is defective in HBdl12-immortalized cells. Immortalized cells were grown on glass coverslips and then fixed with
ice-cold methanol. Immunostaining was performed with antidesmoglein Abs (A and C) and phase contrast (B and D). (A and B) WT12S-immortalized
cells; (C and D) HBdl12-immortalized cells. Photomicrographs were taken at equal magnification.
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1992), and primary epithelial cells transformed by acti-
vated ras (ras) and WT12S (WT12S1ras) or HBdl12
(HBdl121ras) (Douglas et al., 1991) were examined for
the expression of specific characteristics of epithelial
cells. Several clonal and nonclonal cell lines of each type
have been previously generated and characterized with
respect to their immortalization, transformation, and ex-
pression of E1A and ras proteins (Douglas et al., 1991;
Quinlan and Douglas, 1992; Gopalakrishnan et al., 1996;
Fischer et al., 1998), representative examples are shown
here. The levels of synthesis and stability of the wild-type
and mutant proteins are not significantly different. How-
ever, the levels of both are less in the immortalized than
in the transformed cells. Furthermore, the mutations do
not seem to affect the extent of complex formation with
pRb and p300 proteins or the extent of phosphorylation
of the uncomplexed pRB (Gopalakrishnan et al., 1997).
Consistently, the C-terminal mutants activate cells into
the cell cycle as well as wild type. Immediately obvious
was a major morphological difference between the two
ras transformed cell lines. The WT12S1ras cells exhib-
ited typical epithelial morphology, made cell–cell con-
tracts and were tightly attached to substrate (Fig. 1C;
Fischer et al., 1998). In contrast, HBdl121ras cells were
rounded, and had lost both cell–cell and cell–substrate
adhesion (Fig. 1D; Fischer et al., 1998). Thus the pres-
ence of an intact E1A12S C terminus seemed to maintain
to greater extent the epithelial nature of the cells, despite
their being able to grow in soft agar and form tumors in
nude mice (Douglas and Quinlan, 1995). If we examined
epithelial cells immortalized by WT12S or the mutant
HBdl12 but not transformed (i.e., no ras), we observed
that both cell types appeared at least somewhat epithe-
lial and were flat and adhesive to substrate; however, the
HBdl12-immortalized cells did not exhibit the typical cob-
blestone appearance of an epithelial sheet (Fig. 1B),
while the WT12S-immortalized cells did (Fig. 1A). WT12S
cells were never seen as single cells and could not be
plated at low density, but HBdl12 cells were able to
survive and expand from single cells.
All the cell lines expressed cytokeratin intermediate
filaments (Figs. 1E–1H), indicative of their epithelial ori-
gin (Georgatos and Maison, 1996; Chou et al., 1997).
Thus, HBdl12-expressing cells did not totally lose their
differentiation program even in the presence of onco-
genic ras. Desmosomes are intercellular adhesion com-
plexes that associate with intermediate filaments, such
as cytokeratins in epithelial cells (Garrod et al., 1996;
Georgatos and Maison, 1996; Green and Jones, 1996).
Examination of the expression and intracellular distribu-
tion of desmoglein, a transmembrane component of des-
mosomes, was conducted using anti-desmoglein Abs
and indirect immunofluorescence (Fig. 2). No cell surface
expression of desmoglein was observed in the presence
of HBdl12 (Fig. 2C). Desmoglein at the cell junctions was
observed in the presence of WT12S (Fig. 2A), especially
in those cells located in the center of large islands.
Regardless of the presence of keratin filaments, desmo-
somes were only correctly expressed in WT12S-immor-
talized epithelial cells and not in HBdl12-immortalized
cells.
Tight junction function, but not ZO-1 expression, is
lost in mutant-expressing cells
A distinguishing feature of epithelial cells is their abil-
ity to form a permeability barrier via tight junctions
(Anderson and Van Itallie, 1995). The polarity of epithelia
FIG. 3. HBdl12-immortalized cells fail to form an impermeable epithelium in vitro. (A) Permeability of confluent monolayers to small molecules. Cells
were grown on transwell filters (0.4 m pore) and maintained for 1 week after achieving confluence with fresh media replacement in both chambers
every day. The apical chamber was then labeled with [32P]g-ATP, and total cpms in both chambers was analyzed at 4 and 12 h postlabeling. The
percentage of total cpm in each chamber is illustrated. The measurements are averages of duplicate wells in two independent experiments. (B)
Expression of ZO-1 at cell surface. Cells were processed for indirect immunofluorescence as described in Materials and Methods. Top, phase
contrast; bottom, anti-ZO-1 immunostain. Photomicrographs were taken at equal magnification.
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in vitro may be measured by several assays (Glasser et
al., 1988). One method is to measure the impermeability
of the epithelium to small molecules as a function of the
tight junctions (Cereijido et al., 1978, 1981; Meza et al.,
1982). Experiments to test the ability of postconfluent
monolayers to prevent the passage of molecules from
the apical to the basal compartment were conducted
(Fig. 3A). When WT12S-immortalized cells were grown on
0.4 m pore transwell filters, they were capable of estab-
lishing a polarized epithelium impermeable to 32P-la-
beled ATP (Fig. 3A). This impermeability was maintained
in the presence of ras, which was surprising since some
transformed cells lose this property (Ojakian, 1981). Even
very confluent monolayers of HBdl12-immortalized cells
were unable to generate an impermeability barrier even
in the absence of ras. Since the HBdl121ras cells fail to
form confluent epithelial monolayers, there was no rea-
son to test them in this assay. Examination of the expres-
sion and subcellular localization of ZO-1 (Fig. 3B), a
constituent of tight junctions, indicated that both immor-
talized cell types expressed it and localized it to the
lateral membrane region, although in HBdl12 cells, it
often appeared in a discontinuous pattern, the signifi-
cance of which is not known at this time. The cells
transformed by WT12S and ras also exhibited a contin-
uous, circumferential ZO-1 distribution. It has been pre-
viously reported that expression and localization of ZO-1
are not sufficient for the formation of impermeable epi-
thelia (Stevenson et al., 1988). Thus the cells expressing
WT12S are able to form an impermeable, polarized epi-
thelium, even in ras-transformed cells, while immortal-
ized cells expressing a hypertransforming mutant have
lost this function, despite not being transformed.
Expression of C-terminal mutant of E1A 12S results in
the loss of function of, but not expression of
adherens junction proteins
Adherens junctions (AJ) are specialized cell–cell con-
tact regions composed of a complex of proteins an-
chored onto actin filaments that are apposed to the
plasma membrane (cortical actin) to form a circumferen-
tial actin filament bundle (CAF) (Geiger and Ayalon, 1992;
Nathke et al., 1993; Takeichi, 1995; Yonemura et al., 1995;
Aberle et al., 1996; Marrs and Nelson, 1996). The adhe-
sion component is a transmembrane glycoprotein, a cad-
herin, dimers of which form homotypic interactions with
dimers of the adjacent cell. The cytoplasmic domain of
cadherin associates with A- and b-catenins. It is a-cate-
nin that mediates the connection of the AJ to actin, and
this is required for cell–cell adhesive function. The ex-
pression and localization of the AJ proteins were exam-
ined by indirect immunofluorescence. Using an antibody
that recognizes the extracellular domain of E-cadherin
and nonpermeabilized cells, it could be seen that E-
cadherin was perijunctionally localized at the cell–cell
boundaries of WT12S cells, but not so in HBdl12 cells
(Fig. 4). Thus E-cadherin fails to be correctly localized at
the surface of HBdl12 cells. Using a mAb that recognizes
the cytoplasmic domain of E-cadherin and permeabilized
cells, the results were similar (Fig. 5). In HBdl12-
immortalized cells, a minor membrane-associated signal
could be detected, which may not be transmembrane,
due to the above observation. The predominant E-
cadherin signal came from intracellular, vesicular struc-
tures (Fig. 5). WT12S was also able to maintain proper
E-cadherin localization in WT12S1ras-transformed cells.
Of course, no surface expression was observed in
HBdl121ras cells. The pattern of immunofluorescent
staining with anti-a- and anti-b-catenin antibodies paral-
leled that of E-cadherin in each cell type (Fig. 5). Thus
expression of AJ proteins in WT12S-immortalized and
WT12S1ras-transformed epithelial cells was similar to
that in the original primary cells (Gopalakrishnan and
Quinlan, 1995; data not shown), while they were all ab-
errantly localized in cells immortalized by the C-terminal
mutant and of course HBdl121ras-transformed cells. To
more precisely examine expression and AJ complex for-
mation, confluent cultures of the mutant- and wild-type-
immortalized cell types were subjected to pulse–chase
FIG. 4. E-cadherin is not expressed at the extracellular surface in
mutant-expressing cells. Immortalized cells were grown on glass cov-
erslips and then fixed with paraformaldehyde (3.7%) without permeabi-
lization. Immunostaining was performed with DECMA-1 antibody to
detect surface expression of E-cadherin. Photomicrographs were taken
at equal magnification, bar equals 30 m.
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conditions, labeling with [35S]translabel, and E-cadherin
was immunoprecipitated. As can be seen in Fig. 6, the
levels of E-cadherin synthesized were not different be-
tween the mutant and WT12S-immortalized cells, neither
was E-cadherin association with b-catenin, which oc-
curs cotranslationally. However, we observed that there
was aberrant processing of E-cadherin in the HBdl12
cells and a failure of a-catenin to associate with the
E-cadherin-b-catenin complex. The stability of E-
cadherin and g-catenin in these cells was severely de-
creased, despite a high degree of confluence of the cells.
Thus mutations in the C terminus of E1A led to defective
subcellular AJ localization and, consequently function,
while WT12S maintained AJ function in immortalized
cells and overcame the disruption of AJs in ras-
transformed cells. In the presence of mutant 12S C ter-
mini, coexpression of activated ras leads to a complete
loss of cell–cell (and cell–substrate) adhesiveness Figs.
1 and 5 and below; (Fischer et al., 1998).
The tyrosine kinase substrate pp120cas, which is
structurally similar to b-catenin, has been shown to as-
sociate with AJ complexes in normal and src transformed
cells (Reynolds et al., 1994). A role for pp120 in cell
adhesion has been suggested. Therefore, we examined
the expression and localization of pp120 in cells immor-
talized by WT12S or HBdl12 or transformed with ras and
WT12S or HBdl12. As can be seen in Fig. 7, pp120cas
was expressed in all the cell types and seemed to be
localized appropriately to the plasma membrane, which
FIG. 5. Expression and localization of adherens junction proteins in E1A-immortalized or cotransformed kidney epithelial cells. BRK cells were
immortalized with either WT12S or HBdl12 or cotransformed with E1A (WT12S or HBdl12) and ras. Cells were grown on glass coverslips for 2–5 days,
then fixed, and permeabilized as described in Materials and Methods. Cells were immunostained with antibodies to the indicated antigens, followed
by TRITC-conjugated secondary antibody. Photomicrographs were taken at equal magnification, bar equals 30 m.
FIG. 6. E-cadherin expression and complex formation in WT12S- or
HBdl12-immortalized epithelial cells. E-cadherin complexes fail to effi-
ciently bind to a-catenin and are unstable in HBdl12-immortalized cells
compared to WT12S-immortalized cells. Cells were allowed to achieve
confluence and then were maintained for 5 days with media changes
every other day. Cells were then pulse labeled with [35S]translabel
methionine and chased with unlabeled methionine for the indicated
times (in minutes). Immunoprecipitations were performed using anti-E-
cadherin Abs, as described in Materials and Methods. The immuno-
complexes were resolved by SDS–PAGE, fluorographed, and autora-
diographed.
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could be detected even in HBdl121ras cells, especially
in the filopodial processes (Fig. 7D). This indicates that
not all membrane targeting was defective in HBdl12-
expressing cells. pp120cas was not detected in E-
cadherin immunoprecipitates from cells expressing
WT12S or HBdl12 (Fig. 6 and unpublished observations).
Whether pp120cas has a role in cell–cell adhesion in this
system remains to be determined.
Differential prominence of actin structures in cells
expressing WT12S or HBdl12
To examine the distribution of actin structures in the
immortalized cells, filamentous actin was visualized by
FITC-conjugated phalloidin (Fig. 8). Both WT12S- and
HBdl12-immortalized cells had actin stress fibers. They
were very fine in WT12S-expressing cells (Fig. 8A) and
were only visible in the basal layers of the cells. How-
ever, they were very prominent in HBdl12-immortalized
cells (Fig. 8B). In contrast, the most prominent actin
structure in WT12S cells was cortical actin filaments,
while little or no CAFs were detectable in HBdl12 cells.
The addition of activated ras resulted in the loss of stress
fibers but not cortical actin or CAFs in the WT12S1ras
cells (Fig. 8C). These actin structures were also lost in
HBdl121ras cells (Fig. 8D), which, instead, exhibited
extensive filopodia and small lamellopodia, with their
typical actin structures.
Focal adhesions are membrane associated com-
plexes at the termini of actin stress fibers and are in-
volved in cell–substrate adhesion (Jockusch et al., 1995;
Burridge et al., 1997; Yamada and Geiger, 1997). The
intracellular distribution of vinculin, a member of this
complex, was examined by indirect immunofluorescence
using vinculin-specific Abs (Fig. 9). Very prominent vin-
culin staining, typical of focal adhesions, was observed
in HBdl12-immortalized cells (Fig. 9C). This was consis-
tent with the prominence of actin stress fibers in these
cells (see above, Figs. 8B and 9D). Vinculin staining in
WT12S-immortalized cells was much less distinct and
only observed in the small lamellopodia on the external
sides of cells located at the edges of colonies (Fig. 9A).
The addition of ras to either of these cell types resulted
in the loss of local adhesions and consequently, the
expression of vinculin (data not shown). From these data,
it would appear that WT12S favors those actin structures
more typical of epithelial cells and the C-terminal dele-
FIG. 7. pp120cas expression and localization is not affected by HBdl12. BRK cells were immortalized with either WT12S or HBdl12 or cotransformed
with E1A (WT12S or HBdl12) and ras. Cells were grown on glass coverslips for 2 days, then fixed with 1% PFA, and permeabilized with TX-100. Cells
were immunostained with antibodies to pp120cas, followed by TRITC-conjugated secondary antibody. (A) WT12S-immortalized cells; (B) HBdl12-
immortalized cells; (C) WT12S1ras transformed cells; (D) HBdl121ras transformed cells. Photomicrographs were taken at equal magnification.
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tion mutation favors those more characteristic of fibro-
blastic cells (Nusrat et al., 1995; Yonemura et al., 1995).
DISCUSSION
The data from the experiments described above sug-
gest that the C terminus of E1A 12S can affect epithelial
specific properties, especially those having to do with
cell–cell interactions, such as AJs, TJs, and desmo-
somes. There is also a preference for those actin struc-
tures associated with epithelial cells, CAFs, which are
important for at least adherens junctions and may influ-
ence other junctional complexes (Anderson and Van
Itallie, 1995). Mutations in the C terminus result in im-
mortalized BRK epithelial cells which have lost the func-
tion of and sometimes expression of components of
those complexes involved in cell–cell interactions. Focal
adhesions, as represented by vinculin, were expressed
in both cell types, however, they were limited to the free
surfaces of cells at the edges of colonies in the case of
WT12S-expressing cells but were visible in all mutant-
expressing cells. Therefore, loss of C-terminal se-
quences from 12S results in the loss of epithelial and the
acquisition of fibroblastic characteristics, resembling an
EMT. Cytokeratin is expressed by cells expressing WT or
FIG. 8. Epithelial actin structures are prominent in WT12S-expressing cells, while fibroblastic actin structures are predominant in HBdl12-
expressing cells. For F-actin staining, cells were fixed with 1% paraformaldehyde, permeabilized with TTX100, and incubated with 1 mg/mL
FITC-conjugated phalloidin. (A) WT12S-immortalized cells; (B) HBdl12-immortalized cells; (C) WT12S1ras transformed cells; (D) HBdl121ras
transformed cells. Photomicrographs were taken at equal magnification.
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mutated 12S, while desmosome structures are lost in
mutant-expressing cells. Addition of ras to WT12S results
in transformed cells that resemble benign transformants
that are well behaved, while coexpression of ras and
C-terminal mutant expressing BRK cells leads to aggres-
sively behaving cells, or hypertransformation (Douglas et
al., 1991; Gopalakrishnan and Quinlan, 1995; Fischer et
al., 1998), and metastases in nude mice (Subramanian et
al., 1989). These data suggest that the expression of
C-terminus-deleted 12S, with its consequential loss of
differentiation, predisposes cells toward a more aggres-
sively transformed phenotype. There is substantial evi-
dence linking the loss of differentiation, especially loss of
AJs, with tumor progression and metastasis of epithelial
cells (Behrens et al., 1989, 1993; Schoenenberger and
Matlin, 1991; Birchmeier and Behrens, 1994; Birchmeier
and Birchmeier, 1995; Birchmeier et al., 1995, 1996; Hay,
1995; Vermeulen et al., 1996). Cytoskeletal and adhesion
proteins are themselves sometimes considered tumor
suppressors (Ben-Ze’ev, 1997).
Adenoviruses exhibit tropisms for epithelial cells, with
different serotypes preferring some epithelial cell types
over others. This is one of the properties of Ads that is
being taken advantage of in gene therapy trials using
Ads as delivery vehicles. In fact, adenoviruses grow
preferentially in epithelial cells and poorly in fibroblasts,
and this is not due to the lack of receptor (Precious and
Russell, 1985). Another property of Ads is that the normal
FIG. 9. Vinculin expression in focal adhesions is maintained in the presence of WT or hypertransforming mutant-expressing epithelial cells. Cells
were fixed with 1% PFA, permeabilized with TTx100. WT12S (A and B) or HBdl12 (C and D) immortalized cells were doubly stained for vinculin (A and
C) and F-actin (B and D). Photomicrographs were taken at equal magnification.
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host cells are quiescent, yet the virus needs the host
DNA replication machinery for its own productive cycle.
To maximize viral replication, the virus encodes a gene to
induce the infected cells to proliferate, this is the E1A
gene (Bellett et al., 1985; Stabel et al., 1985; Kaczmarek et
al., 1986; Quinlan and Grodzicker, 1987). Expression of
the E1A 12S gene is necessary for efficient viral replica-
tion in quiescent cells (Spindler et al., 1985). Thus the
virus has evolved to grow efficiently in quiescent epithe-
lial cells. It would not be surprising that the virus has also
taken advantage of or adapted to other cellular struc-
tures and/or functions for its reproduction. Recently, the
cell adhesion molecules have been implicated in signal
transduction (Fagotto and Gumbiner, 1996; Ben-Ze’ev,
1997; Yamada and Geiger, 1997). Perhaps the virus uti-
lizes one or more of these pathways and therefore needs
for them to be maintained. It is easy to imagine that
cell–cell communication plays a part in the original in-
fectious cycle and/or enhances subsequent rounds of
infection in the adjacent cells. Since the E1A gene is
required for both the lytic and transformation lifestyles of
Ads and it is the first viral gene expressed, it is not
surprising for E1A to incorporate those functions that
interface with the host cell. This would not be unlike the
incorporation of RGDs by the viral penton capsid protein
to take advantage of cell–substrate receptors, the inte-
grins (Hynes, 1992; Clark and Brugge, 1995), as acces-
sory receptor molecules (Wickham et al., 1993). Similarly,
the N terminus of E1A has two sites, CR1 and CR2, that
are able to complex with the host pRB family to usurp
control of the cell cycle (Reviewed in Jansen-Durr, 1996).
It would be interesting to incorporate the C-terminal
mutations into genomic E1A and ascertain whether they
have any effect on the virus productive cycle in the host
animal.
Adenovirus E1A 12S can immortalize primary epithelial
cells (Houweling et al., 1980; Kuppuswamy and Chinna-
durai, 1988; Quinlan et al., 1988), and both exons are
required for this (Quinlan and Douglas, 1992). However,
the cells immortalized by E1A 12S retain their differenti-
ation program (Quinlan and Grodzicker, 1987; Quinlan
and Douglas, 1992). E1A is also capable of cooperating
with some oncogenes to bring about tumorigenic trans-
formation (Ruley, 1983), with different oncogenes requir-
ing different regions. It is these properties that result in
E1A being considered an oncogene. E1A has been
shown to induce differentiation of F9 teratocarcinoma
cells (Montano and Lane, 1987; Quinlan, 1989). However,
E1A has also been shown to inhibit differentiation of
muscle cells from myoblasts, which are mesenchymal
and not epithelial (Webster et al., 1988). The latter has, in
general, been attributed to the protein-binding domains
of the N terminus encoded by exon 1. However, it is also
possible that the presence of an intact C terminus, which
seems to be involved in maintaining epithelial character-
istics, could participate in epithelialization or the preven-
tion of a nonepithelial phenotype. The mutations in the C
terminus do not seem to affect first exon encoded func-
tions such as binding pRB or p300, pRB hyperphospho-
rylation (Gopalakrishnan et al., 1997), or cell cycle pro-
gression (Quinlan and Douglas, 1992). Paradoxically, E1A
has been shown to suppress transformation, tumorige-
nicity, and metastasis and consequently has also been
considered an anti-oncogene or tumor suppressor (Chin-
nadurai, 1992; Bayley and Mymryk, 1994; Mymryk, 1996).
WT E1A suppresses ras and neu transformation ( Sub-
ramanian et al., 1989; Douglas et al., 1991; Yu et al., 1991).
E1A suppresses in vivo tumorigenesis and metastasis
(Pozzatti et al., 1988; Steeg et al., 1988; Boyd et al., 1993).
E1A also promotes epithelial characteristics in some
tumor cell types (Frisch, 1994), thereby partially reversing/
suppressing the transformed phenotype (Gopalakrish-
nan and Quinlan, 1995) or at least diminishing the more
aggressive growth characteristics and this has been
attributed to the C terminus (Subramanian et al., 1989;
Douglas et al., 1991; Linder et al., 1992; Boyd et al., 1993;
Fischer et al., 1998). Mutants that fail to bind to CTBP
also give rise to metastases with an activated ras, while
WT12S does not (Boyd et al., 1993). From the studies
described herein, it would appear that the region of E1A
required for induction/maintenance of epithelialization
and suppression of transformation progression, at least
with ras, is the same. It is possible that the C terminus
could also contribute to the inhibition of nonepithelial
differentiation pathways. The results seem to support the
possibility that some previously observed phenotypes of
E1A may be one and the same. Thus the C terminus of
E1A 12S could be regulating mesenchymal-epithelial
transitions and deletions in this region result in an epi-
thelial-mesenchymal transition, contributing to tumor
progression.
MATERIALS AND METHODS
Cell culture and transfections
Primary baby rat kidney (BRK) cells were isolated
from 3- to 5-day-old rats (Fisher F344; Harlan, India-
napolis, IN) as previously described (Ruley, 1983).
Cells were transfected with either WT12S- or HBdl12-
expressing plasmids (Douglas et al., 1991); along with
a genomic T24 ras plasmid (Traparowsky et al., 1982).
Transfections were done by calcium phosphate pre-
cipitation, essentially as described (Wigler et al., 1979).
Multiple cell lines were cloned from resulting foci, as
well as nonclonal (.15 foci/dish) lines generated, to
reduce contributions to clonal variation (Khrosravi-Far
et al., 1995). For immortalized cell lines, BRK cells were
infected at a multiplicity of infection of 10 with adeno-
viruses containing WT12S or HBdl12 E1A regions. Im-
mortalized cell lines were generated by passaging
entire 60-mm dishes, also reducing the contributions
of clonal variation. The experiments were conducted
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on cell lines that were thawed at the same time and
passaged up to 40 times and then discontinued. Cells
were maintained in DMEM (BioWhittaker, Walkersville,
MD) supplemented with 5% FCS and penicillin/strep-
tomycin (100 IU/ ml; 100 mg/ ml) (DMEM/FCS).
Immunofluorescence analysis
Cells were grown on coverslips for 2–4 days in
DMEM/FCS. Cells were rinsed with PBS or a cytoskele-
ton stabilizing buffer (10 mM HEPES, pH 6.1; 150 mM
NaCl; 5 mM EGTA; 5 mM MgCl2; and 5 mM glucose;
Herzog et al., 1994). Cells were fixed with 3.7 or 1%
paraformaldehyde in PBS for 15 min at room tempera-
ture, followed by permeabilization with 0.2% Triton X-100
in PBS for 3 min. For nonpermeabilized cell-immunoflu-
orescence of E-cadherin, no Triton X-100 incubation was
used. For some antigens, either a 1:1 mixture of acetone/
methanol or 100% methanol (at 220°C) was used as a
fixative. Antibody incubations were carried out in 1%FCS/
PBS at 37°C for 30 min. DECMA-1 clone ascites fluid and
FITC-conjugated phalloidin were purchased from Sigma
(St. Louis, MO); a-catenin, b-catenin, E-cadherin, pp120cas,
and desmoglein antibodies were purchased from Trans-
duction Labs (Lexington, KY) and ZO-1 from Zymed (San
Francisco, CA). Secondary antibody (TRITC-conjugated)
incubations were followed by washing and mounting
with Airvol (Air Products, Allentown, PA). Photomicro-
graphs were taken with a Zeiss Axiophot epifluores-
cence microscope using either TriXPan 400ASA film or
an Optronics DEI-750 video camera coupled to an Inte-
gral Technologies Flashpoint 24-bit Frame Grabber Card.
Equal magnifications were used for all panels in each
figure.
Immunoprecipitations
Cells were grown for 2–7 days in DMEM/FCS. Cells
were labeled with approximately 150 mCi [35S]translabel
methionine (ICN Pharmaceuticals, Inc., Costa Mesa, CA)
in 2 ml methionine-free media for 1 h, plus or minus
chase conditions, the addition of 2 mM cold methionine,
for up to 6 h prior to lysis. Cells were rinsed with cold
PBS once and lysed in cold 1% Nonidet-P-40/0.5% de-
oxycholate (NP-40/DOC) in 50 mM Tris (pH 7.6), 1 mM
sodium vanadate, and 5 mM phenylmethylsulfonylfluo-
ride on ice for 30 min. Lysates were then scraped into
microcentrifuge tubes and centrifuged for 30 min at 4°C.
The supernatant lysates were normalized to each other
by scintillation counting and brought to equal volumes
with lysis buffer. Immunoprecipitations were carried out
at 4°C with the anti-E-cadherin antibodies (Transduction
Laboratories, Lexington, KY), and immune complexes
were collected with 0.3% protein A-Sepharose CL-4B.
Immunoprecipitates were resolved by SDS–PAGE, fluoro-
graphed, and autoradiographed.
Permeability assay
Epithelial permeability assays were essentially per-
formed as previously described (Byers et al., 1992). Cells
were cultured on 0.4 m pore transwell filters for 5–7 days
after initial confluence. Media (DMEM/5%FCS) was re-
placed every other day, keeping the media levels equal
between the two chambers. The apical chamber was
labeled with 1 mCi [32P]g-ATP per 0.5 ml media. Equal
proportion aliquots were taken at 30 min and 4 and 12 h
(Byers et al., 1992), except that at 12 h the entire volume
of media from each camber was collected and the filters
were retained. Media aliquots and filters were assayed
by Cherenkov counting, and the results were plotted as
percentage of total cpm found in each chamber. The data
represent the 12-h time point for each cell type averaged
over duplicate wells in two independent experiments.
The cpm associated with the filter was less than 3% of
total cpm and was not significantly different among the
cell lines tested (data not shown).
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